Write a reviewFor vendors
♡
Home / Investors / Andrew Pang

Andrew Pang

Venture Fund · Hong Kong S.A.R.

About Andrew Pang

Venture capital investor (Consultant) based in Hong Kong S.A.R.. Focus areas include Health Care, Drug Discovery, Genetics. Past investments include Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health.

Investment focus

Sectors
Health CareDrug DiscoveryGeneticsAutoimmune DiseasesWellnessWomen FoundedInvestment ManagementLife SciencePortfolio ManagementMedical TechnologiesVenture FundraisingFinanceBiotechnologyMedical DevicesDrug DevelopmentGenomicsPrecision MedicineNeuroscienceClinical TrialsGene Therapy

Portfolio

No portfolio companies recorded yet; Andrew Pang reports 39 investments overall.

Similar investors

Aakash Patel

Venture Fund · New York City
Health CareCommercialTalent ManagementWearables+16
60Investments
—Exits

Aakash Tulsani

Venture Fund · Singapore
Series BHealth CareHospitalsE-commerceSports+16
60Investments
—Exits

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Bast

Venture Fund · Kitchener
SeedEarly Stage VentureAdvertisingHealth CareAccountingPayments+16
60Investments
—Exits

Aaron Block

Angel Investor · New York City
Early Stage VentureAdvertisingHealth CareWomen FoundedEnterprise Software+16
60Investments
—Exits

Aaron Church

London
Health CareWearablesEquipment ManufacturingE-commerce+16
60Investments
—Exits